Validity assessment of self-reported medication use by comparing to pharmacy insurance claims

Misuzu Fujita, Yasunori Sato, Kengo Nagashima, Sho Takahashi, Akira Hata

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: In Japan, an annual health check-up and health promotion guidance programme was established in 2008 in accordance with the Act on Assurance of Medical Care for the Elderly. A self-reported questionnaire on medication use is a required item in this programme and has been used widely, but its validity has not been assessed. The aim of this study was to evaluate the validity of this questionnaire by comparing self-reported usage to pharmacy insurance claims. Setting: This is a population-based validation study. Self-reported medication use for hypertension, diabetes and dyslipidaemia is the evaluated measurement. Data on pharmacy insurance claims are used as a reference standard. Participants: Participants were 54 712 beneficiaries of the National Health Insurance of Chiba City. Primary and secondary outcome measures: Sensitivity, specificity and κ statistics of the self-reported medication-use questionnaire for predicting actual prescriptions during 1 month (that of the checkup) and 3 months (that of the check-up and the previous 2 months) were calculated. Results: Sensitivity and specificity scores of questionnaire data for predicting insurance claims covering 3 months were, respectively, 92.4% (95% CI 91.9 to 92.8) and 86.4% (95% CI 86.0 to 86.7) for hypertension, 82.6% (95% CI 81.1 to 84.0) and 98.5% (95% CI 98.4 to 98.6) for diabetes, and 86.2% (95% CI 85.5 to 86.8) and 91.0% (95% CI 90.8 to 91.3) for dyslipidaemia. Corresponding κ statistics were 70.9% (95% CI 70.1 to 71.7), 77.1% (95% CI 76.2 to 77.9) and 69.8% (95% CI 68.9 to 70.6). The specificity was significantly higher for questionnaire data covering 3 months compared with data covering 1 month for all 3 conditions. Conclusions: Self-reported questionnaire data on medication use had sufficiently high validity for further analyses. Item responses showed close agreement with actual prescriptions, particularly those covering 3 months.

Original languageEnglish
Article numbere009490
JournalBMJ open
Volume5
Issue number11
DOIs
Publication statusPublished - 2015 Jan 1
Externally publishedYes

Fingerprint

Insurance
Dyslipidemias
Prescriptions
Hypertension
Sensitivity and Specificity
Validation Studies
National Health Programs
Health Promotion
Surveys and Questionnaires
Japan
Outcome Assessment (Health Care)
Health
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Validity assessment of self-reported medication use by comparing to pharmacy insurance claims. / Fujita, Misuzu; Sato, Yasunori; Nagashima, Kengo; Takahashi, Sho; Hata, Akira.

In: BMJ open, Vol. 5, No. 11, e009490, 01.01.2015.

Research output: Contribution to journalArticle

Fujita, Misuzu ; Sato, Yasunori ; Nagashima, Kengo ; Takahashi, Sho ; Hata, Akira. / Validity assessment of self-reported medication use by comparing to pharmacy insurance claims. In: BMJ open. 2015 ; Vol. 5, No. 11.
@article{970e65898e1341629fc0ef54b018f5c7,
title = "Validity assessment of self-reported medication use by comparing to pharmacy insurance claims",
abstract = "Objectives: In Japan, an annual health check-up and health promotion guidance programme was established in 2008 in accordance with the Act on Assurance of Medical Care for the Elderly. A self-reported questionnaire on medication use is a required item in this programme and has been used widely, but its validity has not been assessed. The aim of this study was to evaluate the validity of this questionnaire by comparing self-reported usage to pharmacy insurance claims. Setting: This is a population-based validation study. Self-reported medication use for hypertension, diabetes and dyslipidaemia is the evaluated measurement. Data on pharmacy insurance claims are used as a reference standard. Participants: Participants were 54 712 beneficiaries of the National Health Insurance of Chiba City. Primary and secondary outcome measures: Sensitivity, specificity and κ statistics of the self-reported medication-use questionnaire for predicting actual prescriptions during 1 month (that of the checkup) and 3 months (that of the check-up and the previous 2 months) were calculated. Results: Sensitivity and specificity scores of questionnaire data for predicting insurance claims covering 3 months were, respectively, 92.4{\%} (95{\%} CI 91.9 to 92.8) and 86.4{\%} (95{\%} CI 86.0 to 86.7) for hypertension, 82.6{\%} (95{\%} CI 81.1 to 84.0) and 98.5{\%} (95{\%} CI 98.4 to 98.6) for diabetes, and 86.2{\%} (95{\%} CI 85.5 to 86.8) and 91.0{\%} (95{\%} CI 90.8 to 91.3) for dyslipidaemia. Corresponding κ statistics were 70.9{\%} (95{\%} CI 70.1 to 71.7), 77.1{\%} (95{\%} CI 76.2 to 77.9) and 69.8{\%} (95{\%} CI 68.9 to 70.6). The specificity was significantly higher for questionnaire data covering 3 months compared with data covering 1 month for all 3 conditions. Conclusions: Self-reported questionnaire data on medication use had sufficiently high validity for further analyses. Item responses showed close agreement with actual prescriptions, particularly those covering 3 months.",
author = "Misuzu Fujita and Yasunori Sato and Kengo Nagashima and Sho Takahashi and Akira Hata",
year = "2015",
month = "1",
day = "1",
doi = "10.1136/bmjopen-2015-009490",
language = "English",
volume = "5",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Validity assessment of self-reported medication use by comparing to pharmacy insurance claims

AU - Fujita, Misuzu

AU - Sato, Yasunori

AU - Nagashima, Kengo

AU - Takahashi, Sho

AU - Hata, Akira

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objectives: In Japan, an annual health check-up and health promotion guidance programme was established in 2008 in accordance with the Act on Assurance of Medical Care for the Elderly. A self-reported questionnaire on medication use is a required item in this programme and has been used widely, but its validity has not been assessed. The aim of this study was to evaluate the validity of this questionnaire by comparing self-reported usage to pharmacy insurance claims. Setting: This is a population-based validation study. Self-reported medication use for hypertension, diabetes and dyslipidaemia is the evaluated measurement. Data on pharmacy insurance claims are used as a reference standard. Participants: Participants were 54 712 beneficiaries of the National Health Insurance of Chiba City. Primary and secondary outcome measures: Sensitivity, specificity and κ statistics of the self-reported medication-use questionnaire for predicting actual prescriptions during 1 month (that of the checkup) and 3 months (that of the check-up and the previous 2 months) were calculated. Results: Sensitivity and specificity scores of questionnaire data for predicting insurance claims covering 3 months were, respectively, 92.4% (95% CI 91.9 to 92.8) and 86.4% (95% CI 86.0 to 86.7) for hypertension, 82.6% (95% CI 81.1 to 84.0) and 98.5% (95% CI 98.4 to 98.6) for diabetes, and 86.2% (95% CI 85.5 to 86.8) and 91.0% (95% CI 90.8 to 91.3) for dyslipidaemia. Corresponding κ statistics were 70.9% (95% CI 70.1 to 71.7), 77.1% (95% CI 76.2 to 77.9) and 69.8% (95% CI 68.9 to 70.6). The specificity was significantly higher for questionnaire data covering 3 months compared with data covering 1 month for all 3 conditions. Conclusions: Self-reported questionnaire data on medication use had sufficiently high validity for further analyses. Item responses showed close agreement with actual prescriptions, particularly those covering 3 months.

AB - Objectives: In Japan, an annual health check-up and health promotion guidance programme was established in 2008 in accordance with the Act on Assurance of Medical Care for the Elderly. A self-reported questionnaire on medication use is a required item in this programme and has been used widely, but its validity has not been assessed. The aim of this study was to evaluate the validity of this questionnaire by comparing self-reported usage to pharmacy insurance claims. Setting: This is a population-based validation study. Self-reported medication use for hypertension, diabetes and dyslipidaemia is the evaluated measurement. Data on pharmacy insurance claims are used as a reference standard. Participants: Participants were 54 712 beneficiaries of the National Health Insurance of Chiba City. Primary and secondary outcome measures: Sensitivity, specificity and κ statistics of the self-reported medication-use questionnaire for predicting actual prescriptions during 1 month (that of the checkup) and 3 months (that of the check-up and the previous 2 months) were calculated. Results: Sensitivity and specificity scores of questionnaire data for predicting insurance claims covering 3 months were, respectively, 92.4% (95% CI 91.9 to 92.8) and 86.4% (95% CI 86.0 to 86.7) for hypertension, 82.6% (95% CI 81.1 to 84.0) and 98.5% (95% CI 98.4 to 98.6) for diabetes, and 86.2% (95% CI 85.5 to 86.8) and 91.0% (95% CI 90.8 to 91.3) for dyslipidaemia. Corresponding κ statistics were 70.9% (95% CI 70.1 to 71.7), 77.1% (95% CI 76.2 to 77.9) and 69.8% (95% CI 68.9 to 70.6). The specificity was significantly higher for questionnaire data covering 3 months compared with data covering 1 month for all 3 conditions. Conclusions: Self-reported questionnaire data on medication use had sufficiently high validity for further analyses. Item responses showed close agreement with actual prescriptions, particularly those covering 3 months.

UR - http://www.scopus.com/inward/record.url?scp=84947281053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947281053&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2015-009490

DO - 10.1136/bmjopen-2015-009490

M3 - Article

C2 - 26553839

AN - SCOPUS:84947281053

VL - 5

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 11

M1 - e009490

ER -